On-site Course: Bioinformatics and Clinical Genomics
On-site Course: Bioinformatics and Clinical Genomics
Next available on-site courses:
- March 2nd, 2018, London, UK
- May 4th, 2018, San Gwann, Malta
Express your interest
Instructors: Dr. Darrol J. Baker; The Golden Helix Foundation, London, UK; Prof. Dr. George P. Patrinos; University of Patras, Department of Pharmacy, Patras, Greece
What will this course be delivering?
We will spend two days on your site, delivering a fun, yet intensive, course in clinical genomic and bioinformatics. The course is designed to bridge knowledge gaps between genomics and high-end computing. The course will provide insight into the past, present and future of precision bioinformatics, with particular emphasis on clinical finding of variants. The simple aim being for users to turn up to the class with, in effect, an empty laptop and by the end of class having the basic knowledge and know how to deliver clinical called variants on a set of whole genome data.
Schedule
Day 1 - Understanding the Software, Hardware needs and Designing Pipelines.
On Day 1, we will cover the fundamentals of what you need to run a successful pipeline of genome data: On both the plant and animal side: Installation of software, tools and scaling your IT to cope with genome demand. We will focus on building your genome pipeline and run your first pipeline of data.
Day 2 - Implementation of data: Finding meaning in the data.
On Day 2, we will provide insight into your data and learn about the very good, very bad and very ugly practices used within clinical diagnostics, nutrigenomics and personalised medicine industry. How to spot bad quality data and corrective actions you can make to your data and suppliers.
Post Course
We, if you wish, follow up with you on a quarterly basis to help you with your understanding completely free. We can also consult or offer further in-house training for your groups (see in-house training below)
Objectives
· - Work on your issues and use your data, where ever possible within three days.
· - Get to grips with the fundamentals of whole genome analysis and clinically calling variants.
· - Creating a sustainable and scalable genomics pipelines.
· - Learn about the main aspects of the industry, including key terminology and concepts
· - Understand today’s global landscape of genomic interpretation.
· - Gain insight into public and private initiatives across Americas, Europe and Asia
· - Discover the role of genomic data in the business of clinical diagnostics.
· - Explore business models and options for exploitation of genome-based technologies.
· - Identify commercial opportunities in diagnostics arising from genome data aggregation
· - Understand human factors for market penetration of DNA testing
· - Understand the future of advanced stratified diagnostics in the clinic
· - Analyse leverage your data, datasets and their value
· - Discover the emerging industry of pharmacogenomics and stratified medicine.
· - Learn to translate and commercialise clinical outcomes derived from genome data
· - Identify opportunities in the genomics landscape as part of individual health planning
· - Learn how innovative companies are investing in this new multi-trillion dollar industry
· - Understand how to implement genomic and precision medicine into practice
· - Appreciate the challenges and opportunities in transitioning to precision based care
· - Get to grips with artificial intelligence, machine learning and big data in precision medicine
· - Understand the evolving world of ‘-omics’ and how software is enabling the analysis of vast sums of health data
· - Learn about precision medicine opportunities beyond tumour genome sequencing, cancer therapeutics and metabolic conditions.
Target Audience
These courses are ideally suited to those already working in, and those who would like to enter the Genomic and Precision Medicine disciplines and related technologies, Biopharma, Healthcare and Clinical Research Industries. These include life science industry representatives from pharmaceutical, medical devices and diagnostic industries, clinical innovators, hospital executives, payers, policy makers, multidisciplinary researchers, patient advocates, angel, venture capital investors and academia. However, this industry is evolving and you may not fit the normal target audience, but feel you have something to offer. We have had people from automotive, space sciences, oil exploration and indeed deep-sea discovery taking this course, since programme design and algorithms usages are very similar and can offer ‘a fresh pair of eyes’ to a given issue.